Theralase Technologies Inc. (TLT.V)
CAD 0.27
(0.0%)
CAD 0.27
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.57 Million CAD | 12.91% |
| 2022 | -5.24 Million CAD | -18.84% |
| 2021 | -4.41 Million CAD | 21.25% |
| 2020 | -5.6 Million CAD | 24.48% |
| 2019 | -7.42 Million CAD | -121.23% |
| 2018 | -3.35 Million CAD | 44.91% |
| 2017 | -6.09 Million CAD | -23.82% |
| 2016 | -4.92 Million CAD | 5.51% |
| 2015 | -5.2 Million CAD | -101.28% |
| 2014 | -2.58 Million CAD | -124.57% |
| 2013 | -1.15 Million CAD | 23.67% |
| 2012 | -1.5 Million CAD | -3.82% |
| 2011 | -1.45 Million CAD | -21.19% |
| 2010 | -1.19 Million CAD | -396.62% |
| 2009 | -241.57 Thousand CAD | 78.27% |
| 2008 | -1.11 Million CAD | 0.15% |
| 2007 | -1.11 Million CAD | -294.82% |
| 2006 | -281.99 Thousand CAD | -2287.21% |
| 2005 | 12.89 Thousand CAD | -78.27% |
| 2004 | 59.34 Thousand CAD | 219.52% |
| 2003 | -49.65 Thousand CAD | 0.06% |
| 2002 | -49.68 Thousand CAD | 71.62% |
| 2001 | -175.07 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.26 Million CAD | -27.82% |
| 2024 Q2 | -1.13 Million CAD | 10.5% |
| 2023 Q2 | -1.15 Million CAD | 17.91% |
| 2023 Q3 | -1.01 Million CAD | 12.08% |
| 2023 Q4 | -991.02 Thousand CAD | 2.43% |
| 2023 FY | -4.57 Million CAD | 12.91% |
| 2023 Q1 | -1.4 Million CAD | -58.89% |
| 2022 Q1 | -1.7 Million CAD | -32.84% |
| 2022 Q2 | -1.24 Million CAD | 26.63% |
| 2022 Q3 | -1.41 Million CAD | -13.19% |
| 2022 FY | -5.24 Million CAD | -18.84% |
| 2022 Q4 | -885.74 Thousand CAD | 37.34% |
| 2021 Q1 | -919.09 Thousand CAD | -4.11% |
| 2021 Q2 | -1.14 Million CAD | -24.38% |
| 2021 Q3 | -1.06 Million CAD | 6.62% |
| 2021 Q4 | -1.28 Million CAD | -20.04% |
| 2021 FY | -4.41 Million CAD | 21.25% |
| 2020 Q4 | -882.76 Thousand CAD | 39.04% |
| 2020 Q3 | -1.44 Million CAD | 10.82% |
| 2020 Q2 | -1.62 Million CAD | 1.22% |
| 2020 Q1 | -1.64 Million CAD | 45.48% |
| 2020 FY | -5.6 Million CAD | 24.48% |
| 2019 Q3 | -1.78 Million CAD | -20.18% |
| 2019 FY | -7.42 Million CAD | -121.23% |
| 2019 Q1 | -1.12 Million CAD | -51.08% |
| 2019 Q2 | -1.48 Million CAD | -32.15% |
| 2019 Q4 | -3.01 Million CAD | -68.73% |
| 2018 Q3 | -722.81 Thousand CAD | 18.35% |
| 2018 FY | -3.35 Million CAD | 44.91% |
| 2018 Q4 | -744.7 Thousand CAD | -3.03% |
| 2018 Q1 | -1 Million CAD | 16.32% |
| 2018 Q2 | -885.28 Thousand CAD | 11.83% |
| 2017 Q4 | -1.19 Million CAD | 27.54% |
| 2017 Q3 | -1.65 Million CAD | 6.23% |
| 2017 Q2 | -1.76 Million CAD | -19.95% |
| 2017 Q1 | -1.47 Million CAD | -46.79% |
| 2017 FY | -6.09 Million CAD | -23.82% |
| 2016 Q1 | -1.14 Million CAD | -19.96% |
| 2016 Q3 | -1.46 Million CAD | -17.48% |
| 2016 Q4 | -1 Million CAD | 31.4% |
| 2016 FY | -4.92 Million CAD | 5.51% |
| 2016 Q2 | -1.24 Million CAD | -8.61% |
| 2015 Q1 | -933.64 Thousand CAD | -9.87% |
| 2015 FY | -5.2 Million CAD | -101.28% |
| 2015 Q4 | -955.06 Thousand CAD | 51.62% |
| 2015 Q3 | -1.97 Million CAD | -46.71% |
| 2015 Q2 | -1.34 Million CAD | -44.11% |
| 2014 Q2 | -345.65 Thousand CAD | -0.46% |
| 2014 FY | -2.58 Million CAD | -124.57% |
| 2014 Q1 | -344.07 Thousand CAD | 38.04% |
| 2014 Q3 | -1.04 Million CAD | -203.2% |
| 2014 Q4 | -849.78 Thousand CAD | 18.92% |
| 2013 Q1 | -332.43 Thousand CAD | 34.63% |
| 2013 FY | -1.15 Million CAD | 23.67% |
| 2013 Q4 | -555.33 Thousand CAD | -198.9% |
| 2013 Q3 | -185.79 Thousand CAD | -136.24% |
| 2013 Q2 | -78.64 Thousand CAD | 76.34% |
| 2012 Q4 | -508.52 Thousand CAD | -45.93% |
| 2012 Q3 | -348.47 Thousand CAD | -74.87% |
| 2012 Q2 | -199.28 Thousand CAD | 56.04% |
| 2012 Q1 | -453.28 Thousand CAD | -101.0% |
| 2012 FY | -1.5 Million CAD | -3.82% |
| 2011 FY | -1.45 Million CAD | -21.19% |
| 2011 Q4 | -225.52 Thousand CAD | 46.8% |
| 2011 Q1 | -447.26 Thousand CAD | -38.57% |
| 2011 Q2 | -357.26 Thousand CAD | 20.12% |
| 2011 Q3 | -423.92 Thousand CAD | -18.66% |
| 2010 Q3 | -402.23 Thousand CAD | -102.6% |
| 2010 Q4 | -322.77 Thousand CAD | 19.76% |
| 2010 Q2 | -198.53 Thousand CAD | 28.12% |
| 2010 FY | -1.19 Million CAD | -396.62% |
| 2010 Q1 | -276.18 Thousand CAD | -406.22% |
| 2009 Q1 | -217.25 Thousand CAD | 29.55% |
| 2009 Q2 | -27.35 Thousand CAD | 87.41% |
| 2009 Q4 | 90.19 Thousand CAD | 203.47% |
| 2009 Q3 | -87.16 Thousand CAD | -218.63% |
| 2009 FY | -241.57 Thousand CAD | 78.27% |
| 2008 Q1 | -339.94 Thousand CAD | 54.71% |
| 2008 Q4 | -308.39 Thousand CAD | -28.1% |
| 2008 Q3 | -240.75 Thousand CAD | -8.16% |
| 2008 Q2 | -222.58 Thousand CAD | 34.52% |
| 2008 FY | -1.11 Million CAD | 0.15% |
| 2007 Q4 | -750.52 Thousand CAD | -289.71% |
| 2007 FY | -1.11 Million CAD | -294.82% |
| 2007 Q1 | -75.08 Thousand CAD | 81.99% |
| 2007 Q2 | -95.17 Thousand CAD | -26.77% |
| 2007 Q3 | -192.58 Thousand CAD | -102.35% |
| 2006 Q2 | 55.61 Thousand CAD | -25.37% |
| 2006 FY | -281.99 Thousand CAD | -2287.21% |
| 2006 Q4 | -416.97 Thousand CAD | -8716.86% |
| 2006 Q1 | 74.51 Thousand CAD | 578.42% |
| 2006 Q3 | 4839.00 CAD | -91.3% |
| 2005 FY | 12.89 Thousand CAD | -78.27% |
| 2005 Q2 | 40.96 Thousand CAD | 583.36% |
| 2005 Q3 | -4017.00 CAD | -109.81% |
| 2005 Q4 | -15.57 Thousand CAD | -287.75% |
| 2005 Q1 | -8474.00 CAD | -106.94% |
| 2004 Q3 | -14.61 Thousand CAD | 68.92% |
| 2004 Q2 | -47.03 Thousand CAD | -3954.83% |
| 2004 FY | 59.34 Thousand CAD | 219.52% |
| 2004 Q4 | 122.15 Thousand CAD | 935.71% |
| 2004 Q1 | -1160.00 CAD | 87.3% |
| 2003 Q2 | -11.32 Thousand CAD | 11.19% |
| 2003 Q1 | -12.75 Thousand CAD | -9.88% |
| 2003 FY | -49.65 Thousand CAD | 0.06% |
| 2003 Q4 | -9134.00 CAD | 44.42% |
| 2003 Q3 | -16.43 Thousand CAD | -45.07% |
| 2002 Q1 | -11.23 Thousand CAD | 0.0% |
| 2002 Q4 | -11.6 Thousand CAD | 27.37% |
| 2002 FY | -49.68 Thousand CAD | 71.62% |
| 2002 Q3 | -15.98 Thousand CAD | -47.25% |
| 2002 Q2 | -10.85 Thousand CAD | 3.41% |
| 2001 FY | -175.07 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -18.94 Million CAD | 75.872% |
| Therma Bright Inc. | -3.76 Million CAD | -21.315% |
| VentriPoint Diagnostics Ltd. | -4.87 Million CAD | 6.179% |